Anne Coleman to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Anne Coleman has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.412
-
Socioeconomic Disparities in Intravitreal Injection Use and Anti-VEGF Agent Selection: Aflibercept/Ranibizumab Versus Bevacizumab. Clin Ther. 2025 Aug; 47(8):559-565.
Score: 0.238
-
Ophthalmic Immune-Related Adverse Events after Anti-CTLA-4 or PD-1 Therapy Recorded in the American Academy of Ophthalmology Intelligent Research in Sight Registry. Ophthalmology. 2021 06; 128(6):910-919.
Score: 0.174